Mac4Me
@mac4me.bsky.social
Opening new doors in cancer immunotherapy.
A European doctoral network aiming to provide new treatment options for metastatic neuroblastoma, prostate and breast tumours.
More information: https://mac4me.eu/
A European doctoral network aiming to provide new treatment options for metastatic neuroblastoma, prostate and breast tumours.
More information: https://mac4me.eu/
📢 The Mac4Me Doctoral Network is opening up some of our specialized online training modules (originally for our doctoral candidates) to the public! 🔬
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
Online seminar series November 2025 - Mac4me
The European doctoral network Mac4Me (Macrophage Targets for Metastatic Treatment) launched with a virtual meeting on 12 February 2025. Simultaneously, it also launched its digital and social media pr...
mac4me.eu
October 29, 2025 at 11:17 AM
📢 The Mac4Me Doctoral Network is opening up some of our specialized online training modules (originally for our doctoral candidates) to the public! 🔬
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
"Who Owns Our Knowledge?" is the theme for Open Access (OA) Week 💡 (www.openaccessweek.org)
This is the right question for a time of disruption. Who controls the research produced by the community?
Our doctoral network aligns with Open Science.
This is the right question for a time of disruption. Who controls the research produced by the community?
Our doctoral network aligns with Open Science.
International Open Access Week
International Open Access Week is held annually to inspire global momentum toward the open sharing of knowledge in order to address important social issues affecting people around the world. Open Acce...
www.openaccessweek.org
October 22, 2025 at 8:55 AM
"Who Owns Our Knowledge?" is the theme for Open Access (OA) Week 💡 (www.openaccessweek.org)
This is the right question for a time of disruption. Who controls the research produced by the community?
Our doctoral network aligns with Open Science.
This is the right question for a time of disruption. Who controls the research produced by the community?
Our doctoral network aligns with Open Science.
In the context of Breast Cancer Awareness Month 🎀, October 19th marks the International Day against Breast Cancer🎗.
It is a moment to stand in solidarity with the millions worldwide affected by this disease. We acknowledge the resilience of patients and those navigating life after diagnosis.
It is a moment to stand in solidarity with the millions worldwide affected by this disease. We acknowledge the resilience of patients and those navigating life after diagnosis.
Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯
Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.
#MetastaticBreastCancerAwarenessDay
Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.
#MetastaticBreastCancerAwarenessDay
October 19, 2025 at 4:14 PM
In the context of Breast Cancer Awareness Month 🎀, October 19th marks the International Day against Breast Cancer🎗.
It is a moment to stand in solidarity with the millions worldwide affected by this disease. We acknowledge the resilience of patients and those navigating life after diagnosis.
It is a moment to stand in solidarity with the millions worldwide affected by this disease. We acknowledge the resilience of patients and those navigating life after diagnosis.
Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯
Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.
#MetastaticBreastCancerAwarenessDay
Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.
#MetastaticBreastCancerAwarenessDay
October 13, 2025 at 10:30 AM
Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯
Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.
#MetastaticBreastCancerAwarenessDay
Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.
#MetastaticBreastCancerAwarenessDay
Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.
September 24, 2025 at 9:06 AM
Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.
Reposted by Mac4Me
Hugely excited to meet the @mac4me.bsky.social team in Rotterdam for our kick-off meeting. Here with @peptimatrix.bsky.social and a whole interdisciplinary team ’opening new doors in cancer immunotherapy’ www.mac4me.eu
June 26, 2025 at 9:28 AM
Hugely excited to meet the @mac4me.bsky.social team in Rotterdam for our kick-off meeting. Here with @peptimatrix.bsky.social and a whole interdisciplinary team ’opening new doors in cancer immunotherapy’ www.mac4me.eu
Reposted by Mac4Me
The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado.
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
Mac4Me Project Kicks off in Rotterdam
Mac4Me project kicks off with a meeting in Rotterdam and the first doctoral training session.
www.peptimatrix.com
July 8, 2025 at 11:19 AM
The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado.
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!
July 8, 2025 at 2:52 PM
🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!
On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through.
Learn more at mac4me.eu
Learn more at mac4me.eu
Home - Mac4me
Mac4me is dedicated to advancing metastatic neuroblastoma treatment through innovative research and immunotherapy solutions
mac4me.eu
April 18, 2025 at 10:46 AM
On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through.
Learn more at mac4me.eu
Learn more at mac4me.eu
On this #WomensDay, we recognise the impact of breast cancer on women around the world. Today, we remark the dedication of female researchers who are advancing metastasis understanding and the vital role of women's perspectives in shaping more effective and inclusive cancer care and research.
March 8, 2025 at 9:29 AM
On this #WomensDay, we recognise the impact of breast cancer on women around the world. Today, we remark the dedication of female researchers who are advancing metastasis understanding and the vital role of women's perspectives in shaping more effective and inclusive cancer care and research.
🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.
February 13, 2025 at 2:49 PM
🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.